Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter International Single-blind Randomized Comparative Clinical Study of the Efficacy and Safety of GNR-068 (45 mg) and Stelara® (45 mg) and Assessment of the Safety, Tolerability and Long-term Effectiveness of GNR-068 in Patients With Moderate and Severe Forms of Plaque Psoriasis

NCT06488664 is registered in ClinicalTrials.gov with AO GENERIUM as lead sponsor.

NCT NCT06488664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06488664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter International Single-blind Randomized Comparative Clinical Study of the Efficacy and Safety of GNR-068 (45 mg) and Stelara® (45 mg) and Assessment of the Safety, Tolerability and Long-term Effectiveness of GNR-068 in Patients With Moderate and Severe Forms of Plaque Psoriasis
Lead sponsor
AO GENERIUM
Phase
Phase 3
Overall status
Completed
Start date
July 25, 2023
Completion date
November 26, 2025
Enrollment
422 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis